CTNM
Contineum Therapeutics Inc.
$11.27
-$1.23(-9.84%)
66
Overall
--
Value
66
Tech
--
Quality
Market Cap
$333.00M
Volume
156.04K
52W Range
$3.35 - $20.24
Target Price
$22.80
EPS Estimates Overview
| Current Quarter | $-0.55 | Next Quarter | $-0.58 |
| Current Year | $-2.31 | Next Year | $-2.34 |
| QoQ Growth | -5.5% | YoY Growth | -1.3% |
| 3Y EPS CAGR | N/A | Target Price | $22.80 |
| Consensus | Buy | Upside | +102.3% |
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CTNM | $11.27 | -9.8% | 156.04K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Contineum Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW